Skip to main content

Hepatitis C clinical trials at UC Davis
1 research study open to eligible people

  • The Patient-Reported Outcomes Project of HCV-TARGET

    “This research study looks at how often a neuromuscular disease called Pompe disease occurs in the United States.”

    open to eligible people ages 21 years and up

    The PROP UP research study is funded by The Patient Centered Outcomes Research Institute (PCORI). PROP UP is a multi-centered prospective observational study that will evaluate all-oral treatment regimens for HCV regarding several patient-reported outcomes (PROs) such as HCV-associated symptoms, treatment side effects, medication adherence, out of pocket costs, comorbid conditions, and long-term benefits of cure and harms of treatment to compare PROs of different treatment regimens, treatment durations, and patient subgroups. Participants will be recruited from 9 U.S. liver centers. Approximately 1920 patients with HCV infection who are prescribed a regimen containing Harvoni®, Viekera Pak®, Zepatier®, DAC/SOF or SOF/VEL for chronic HCV will be recruited and approximately 1600 patients who are approved and begin HCV treatment will be enrolled in the longitudinal study. PRO surveys will be evaluated before, during and after HCV treatment. PROP UP is a collaborative effort between behavioral and biomedical researchers, a patient engagement group and a patient advocacy organization.

    Davis, California and other locations

Last updated: